Current SATVI news
SATVI researchers have just published an article titled: "Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial" appearing in the Lancet Respiratory Medicine journal.
SATVI researcher Professor Tom Scriba has co-authored a research paper titled "Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state" appearing in the PLoS One journal.
SATVI researchers Professors Mark Hatherill, Tom Scriba, Doctors Darboe, Penn-Nicholson, Mbandi, Nicole Bilek, SImba Mabwe have authored a research paper titled "Detection of Tuberculosis recurrence, diagnosis and treatment response by a blood transcriptomic risk signature in HIV-infected persons on Antiretroviral Therapy" appearing in the Frontiers in Microbiology journal.
SATVI researchers Professors Mark Hatherill, Tom Scriba, Humphrey Mulenga and Doctors Eric Bunyase, Mbandi, Mendelsohn, Kagina and Penn-Nicholson have authored a research paper titled: "Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol" appearing in the British Medical Journal.
SATVI researchers Profesors Mark Hatherill, Tom Scriba, Doctors Bunyasi, Geldenhuys, Mulenga, Shenje, Luabeya, Tameris, Nemes, Rozot have authored a research paper titled "Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents" appearing in the International Journal of Tuberculosis and Lung Disease.
Professor Mark Hatherill has co-authored a article titled: "Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies" appearing in the Lancet Respiratory Medicine journal.
Cheleka Mpande, SATVI researcher features in the latest online Keystone Symposium in which she explains the paper titled “Functional, antigen-specific stem cell memory (TSCM) CD4+ T cells are induced by human M.tuberculosis infection”
Professor Tom Scriba has co-authored a paper titled: "Moving tuberculosis vaccines from theory to practice" appearing in the Nature Reviews Immunology Journal.
SATVI invites applications to several positions at its Worcester field site office.
SATVI authors Drs. Adam Penn-Nicholson, Stanley Kimbung Mbandi, Michelle Fisher, Professors Mark Hatherill and Tom Scriba have co-authored a paper titled "Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study" appearing in the Plos Medicine journal.
University of Cape Vice Chancellor, Professor Mamokgethi Phakeng announced the South African Tuberculosis Vaccine Initiative (SATVI) as the winner of the 2018 Vice Chancellor Social Responsiveness Award during the April 2019 Health Faculty Sciences graduation.